It also mitigated non-alcoholic fatty liver disease (NAFLD) by enhancing ALDH2 activity, promoting ROS elimination, and suppressing lipogenesis [70]. The gene discussed is ALDH2; the disease is metabolic dysfunction-associated steatotic liver disease.